Upload
duongkhanh
View
255
Download
1
Embed Size (px)
Citation preview
Patient: SAMPLEPATIENT
DOB: Sex: MRN:
© Genova Diagnostics · A. L. Peace-Brewer, PhD, D(ABMLI), Lab Director · CLIA Lic. #34D0655571 · Medicare Lic. #34-8475
Omega 3 Fatty Acids Omega 6 Fatty Acids
>= 0.09 wt %0.14
>= 0.16 wt %0.86
>= 1.14 wt %2.53
>= 2.1 wt %7.3
>= 3.8 10.9
10.5-16.9 wt %9.6
0.03-0.13 wt %0.09
>= 1.19 wt %1.10
15-21 wt %22
1.50-4.20 wt %3.24
<= 0.26 wt %0.18
30.5-39.736.4
Cardiovascular Risk
Saturated Fatty Acids
Delta - 6 Desaturase Activity
Monounsaturated Fats
Omega 9 Fatty Acids
10-13 wt %11
2.1-3.5 wt %3.2
13.3-16.614.2 <= 0.64 wt %0.24
<= 1.13 wt %0.65
<= 0.59 wt %0.27
39.8-43.637.4
18-23 wt %17
14-17 wt %16
0.22-0.37 wt %0.27
0.07-0.15 wt %0.11
0.22-0.35 wt %0.23
0.92-1.68 wt %0.98
0.12-0.18 wt %0.22
2.1-3.8 wt %2.9
6.0-12.38.7
3.4-10.73.4
12-12526
>= 4.0 8.2
GDX-4-181
ID: Patie t: nt: SAMPLE PATIENT Page 2
© Genova Diagnostics · A. L. Peace-Brewer, PhD, D(ABMLI), Lab Director · CLIA Lic. #34D0655571 · Medicare Lic. #34-8475
Essential Fatty Acid Metabolism
0.14 9.6
0.09
1.10
22
3.24
0.86
2.53
7.3
This test was developed and its performance characteristics determined by Genova Diagnostics, Inc. It has not been cleared or approved by the U.S. Food and Drug
Administration.